Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held N/A

Habib J Dable Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2021
SELL
Disposition due to a tender of shares in a change of control transaction
-
98,450 Reduced 100.0%
0 Common Stock
Jul 02 2021
SELL
Open market or private sale
$5,377,449 $127.47 p/Share
42,186 Reduced 30.0%
98,450 Common Stock
Jul 02 2021
BUY
Exercise of conversion of derivative security
$1,478,197 $35.04 p/Share
42,186 Added 23.07%
140,636 Common Stock
Jul 01 2021
SELL
Open market or private sale
$7,336,597 $126.9 p/Share
57,814 Reduced 37.0%
98,450 Common Stock
Jul 01 2021
BUY
Exercise of conversion of derivative security
$2,025,803 $35.04 p/Share
57,814 Added 27.01%
156,264 Common Stock
Jan 29 2021
BUY
Grant, award, or other acquisition
-
16,662 Added 14.47%
98,450 Common Stock
Jan 05 2021
SELL
Open market or private sale
$518,497 $121.77 p/Share
4,258 Reduced 4.95%
81,788 Common Stock
Jan 04 2021
SELL
Payment of exercise price or tax liability
$407,488 $124.31 p/Share
3,278 Reduced 3.67%
86,046 Common Stock

Also insider at

BPMC
Blueprint Medicines Corp Healthcare
ALBO
ALBIREO PHARMA, INC. Healthcare
PEPG
PepGen Inc. Healthcare
AVTE
Aerovate Therapeutics, Inc. Healthcare
DAWN
Day One Biopharmaceuticals, Inc. Healthcare
HJD

Habib J Dable

CEO and President
Boston, MA

Track Institutional and Insider Activities on XLRN

Follow ACCELERON PHARMA INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XLRN shares.

Notify only if

Insider Trading

Get notified when an Acceleron Pharma Inc insider buys or sells XLRN shares.

Notify only if

News

Receive news related to ACCELERON PHARMA INC

Track Activities on XLRN